Ftse Mib
37.977,59
0,18%
DAX
22.513,42
-0,43%
S&P 500
6.114,63
-0,01%
NASDAQ
20.026,77
0,41%
Bitcoin
97.254,33
-0,35%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Novavax Inc (NVAX) Novavax Inc (NVAX) Notizie

NVAX

Novavax (NVAX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NVAX
DataOraFonteTitoloSimboloCompagnia
06/02/202501:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NVAXNovavax Inc
13/01/202513:50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NVAXNovavax Inc
02/01/202522:02Edgar (US Regulatory)Form 144/A - Report of proposed sale of securities: [Amend]NASDAQ:NVAXNovavax Inc
26/12/202416:31Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NVAXNovavax Inc
13/12/202414:00PR Newswire (US)Novavax Advances Corporate Growth Strategy Through Sanofi Partnership, Including Achievement of First $50 Million MilestoneNASDAQ:NVAXNovavax Inc
10/12/202414:00PR Newswire (US)Novavax Initiates Phase 3 Trial for COVID-19-Influenza Combination and Stand-Alone InfluenzaNASDAQ:NVAXNovavax Inc
04/12/202408:00PR Newswire (US)Novavax Announces Sale of Czech Republic Manufacturing Site to Novo Nordisk for $200 MillionNASDAQ:NVAXNovavax Inc
15/11/202413:47PR Newswire (US)Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)NASDAQ:NVAXNovavax Inc
13/11/202414:00PR Newswire (US)Novavax to Participate in Jefferies London Healthcare ConferenceNASDAQ:NVAXNovavax Inc
12/11/202422:08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NVAXNovavax Inc
12/11/202414:02PR Newswire (US)Novavax Reports Third Quarter 2024 Financial Results and Operational HighlightsNASDAQ:NVAXNovavax Inc
11/11/202414:30PR Newswire (US)U.S. FDA Removes Clinical Hold on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 TrialNASDAQ:NVAXNovavax Inc
04/11/202422:30PR Newswire (US)Novavax to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Operational Highlights on November 12, 2024NASDAQ:NVAXNovavax Inc
04/11/202412:00PR Newswire (US)Åsa Manelius Named Managing Director of Novavax AB SiteNASDAQ:NVAXNovavax Inc
16/10/202414:14PR Newswire (US)Update on Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Phase 3 TrialNASDAQ:NVAXNovavax Inc
09/10/202413:00PR Newswire (US)Novavax's Updated 2024-2025 Nuvaxovid™ COVID-19 Vaccine Receives Authorization in the EUNASDAQ:NVAXNovavax Inc
25/09/202414:00PR Newswire (US)Novavax Names Dr. Ruxandra Draghia-Akli as New Executive Vice President and Head of Research & DevelopmentNASDAQ:NVAXNovavax Inc
13/09/202415:25PR Newswire (US)Novavax 2024-2025 Formula COVID-19 Vaccine Available at Major Pharmacies Across the U.S.NASDAQ:NVAXNovavax Inc
04/09/202415:25PR Newswire (US)Novavax to Participate in Upcoming September ConferencesNASDAQ:NVAXNovavax Inc
30/08/202422:19PR Newswire (US)Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.NASDAQ:NVAXNovavax Inc
08/08/202422:15Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NVAXNovavax Inc
08/08/202414:02PR Newswire (US)Novavax Reports Second Quarter 2024 Financial Results and Operational HighlightsNASDAQ:NVAXNovavax Inc
08/08/202411:55IH Market NewsU.S. Index Futures Drop, Signaling Ongoing Market Volatility; Oil Prices StallNASDAQ:NVAXNovavax Inc
01/08/202415:25PR Newswire (US)Novavax to Host Conference Call to Discuss Second Quarter 2024 Financial Results and Operational Highlights on August 8, 2024NASDAQ:NVAXNovavax Inc
31/07/202411:55IH Market NewsASML Rises 7% on Export Waiver; Intel Plans Layoffs, HSBC $3B Buyback Announced, and MoreNASDAQ:NVAXNovavax Inc
02/07/202414:30PR Newswire (Canada)Novavax Submits Application to Health Canada for Updated Protein-based 2024-2025 Formula COVID-19 VaccineNASDAQ:NVAXNovavax Inc
24/06/202415:18PR Newswire (US)Novavax Submits Application to European Medicines Agency for Updated Protein-based 2024-2025 Formula COVID-19 VaccineNASDAQ:NVAXNovavax Inc
14/06/202420:05PR Newswire (US)Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 VaccineNASDAQ:NVAXNovavax Inc
05/06/202403:35Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:NVAXNovavax Inc
30/05/202415:25PR Newswire (US)Novavax to Participate in 2024 Jefferies Global Healthcare ConferenceNASDAQ:NVAXNovavax Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:NVAX

La tua Cronologia

BIT
UCG
Unicredit
BIT
TIT
Telecom Italia
BIT
MONC
Moncler
BIT
STLAM
Stellantis NV
BIT
ISP
Intesa Sanpaolo
BIT
LDO
Leonardo
BIT
RACE
Ferrari NV
BIT
IP
Interpump
BIT
TITR
Telecom Italia
BIT
ENI
Eni
BIT
ENEL
Enel
BIT
SPM
Saipem
BIT
BMPS
Banca Monte Dei Paschi D...
BIT
BAMI
Banco BPM
BIT
IVG
Iveco Group NV
BIT
G
Generali
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci